Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
15,448,326
-
Share change
-
-305,138
-
Total reported value
-
$131,308,412
-
Price per share
-
$8.50
-
Number of holders
-
64
-
Value change
-
-$9,272,150
-
Number of buys
-
34
-
Number of sells
-
33
Institutional Holders of RA PHARMACEUTICALS INC - COM (RARX) as of Q4 2017
As of 31 Dec 2017,
RA PHARMACEUTICALS INC - COM (RARX) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,448,326 shares.
The largest 10 holders included
NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, Novo Holdings A/S, RA CAPITAL MANAGEMENT, LLC, BlackRock Inc., Rock Springs Capital Management LP, VHCP Management II, LLC, MILLENNIUM MANAGEMENT LLC, Vanguard Group Inc, and Tekla Capital Management LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.